Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Exploiting antifungal immunity in the clinical context322
Editorial Board93
Cellular stress and macrophage activation92
Differential immune responses behind different celiac disease manifestations80
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells79
Editorial Board76
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity76
Three’s company: The cooperative signals behind the differentiation of Th9 cells76
Microbial metabolites and immunotherapy: Basic rationale and clinical indications67
Pyroptosis modulation by bacterial effector proteins64
Aging of lymphoid stromal architecture impacts immune responses59
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi58
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity54
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges53
Local and Cell-intrinsic complement: The new player in cancer progression51
Immunity to pathogenic fungi in the eye45
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity44
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls43
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease42
IL-1 family members as regulators of lymphoid type-2 immunity in cancer42
The noncanonical inflammasome-induced pyroptosis and septic shock39
Pyroptosis: A road to next-generation cancer immunotherapy39
Pyroptosis and the cellular consequences of gasdermin pores38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity38
Interplay between the complement system and other immune pathways in the tumor microenvironment36
Western diet influences on microbiome and carcinogenesis35
Autoimmune diabetes and targets for immunomodulation32
Immunity to fungi: Editorial overview32
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment32
Adaptive NK cell response to human cytomegalovirus: Facts and open issues31
The paradox of aging: Aging-related shifts in T cell function and metabolism31
TREM2: A new player in the tumor microenvironment31
Neuroimmune interactions between itch neurons and skin microbes31
Interleukin-1β and cancer immune response29
The evolving biology of cross-presentation28
Antigen discovery for the development of cancer immunotherapy28
Thymus aging and immune reconstitution, progresses and challenges27
Sialic acid and Siglec receptors in tumor immunity and immunotherapy26
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy25
Diverse IL-9-secreting T helper cells direct responses in the allergic lung25
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases25
Introduction to the Special Issue: Nutrition, microbiota and immunity25
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity24
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination24
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs24
T cell control of SARS-CoV-2: When, which, and where?24
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity23
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders23
T cell fate decisions during memory cell generation with aging23
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?22
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy22
Editorial Board22
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice21
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells21
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy21
The glycoimmune landscape in health and disease21
Proteostasis in T cell aging21
0.044265031814575